Origin Merchant Partners (“Origin”) is pleased to announce that it served as the exclusive financial advisor to Centricity Research (“Centricity” or the “Company”) on a sale of a majority stake by its shareholders, Persistence Capital Partners and management, to Trinity Hunt Partners (“THP”).
Centricity is the operating company formed through the integration of three research network organizations (LMC Manna Research, iACT Health, and Aventiv Research). The Company is a leading clinical research services provider to pharmaceutical sponsors and CRO’s, and specializes in conducting Phase I-IV clinical trials across more than 40 therapeutic areas, from its 35 locations spanning the US and Canada. Centricity’s centralized processes, expansive patient recruitment capabilities, integrated technology, and dedicated team of clinical research professionals have successfully led to over 2,500 studies conducted and more than 100 FDA and Health Canada drug approvals.
THP is a growth-oriented private equity firm headquartered in Dallas, Texas with over $1.7 billion of assets under management, focused on building leading business, healthcare, and consumer services companies. The firm has invested in more than 28 platform companies over the past 17 years.
Origin Senior Leads: Lindsay Adam Weiss, Cathy Steiner, Christopher Solda.
